Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Restrictive cardiomyopathy]

J M Langlard1

  • 1Clinique cardiologique et des maladies vasculaires, hôpital G. & R. Laennec, Nantes.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|January 19, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy.

Heart (British Cardiac Society)·2002
Same author

[Familial hypertrophic cardiomyopathy. French study of the duration and outcome of pregnancy].

Archives des maladies du coeur et des vaisseaux·2002
Same author

[Can one die of sorrow?].

Archives des maladies du coeur et des vaisseaux·2002
Same author

[Hypertrophic cardiomyopathy. Long-term clinical development in a regional cohort of 243 patients].

Archives des maladies du coeur et des vaisseaux·2001
Same author

[Cardiomyopathies. Symptoms, prognosis, treatment].

La Revue du praticien·2001
Same author

Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene.

Circulation·1998

Restrictive cardiomyopathies, rare heart muscle diseases, involve impaired diastolic filling. Diagnosis can be challenging, requiring various investigations, with treatment focusing on symptom management and complication prevention.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Internal Medicine

Context:

  • Restrictive cardiomyopathies are the rarest form of cardiomyopathy, characterized by impaired ventricular filling and reduced diastolic volume.
  • These conditions may be idiopathic, familial, or secondary to other diseases like amyloidosis or hypereosinophilic syndrome.
  • Clinical presentation often mimics other cardiac conditions, complicating diagnosis.

Purpose:

  • To review the characteristics, diagnostic challenges, and management strategies for restrictive cardiomyopathies.
  • To highlight the differential diagnosis between restrictive cardiomyopathy and constrictive pericarditis.
  • To discuss current and emerging therapeutic approaches, particularly for amyloidosis-associated restrictive cardiomyopathy.

Summary:

Related Experiment Videos

  • Restrictive cardiomyopathy presents with diastolic dysfunction, normal ventricular wall thickness, and preserved systolic function, often with increased interstitial fibrosis.
  • Symptoms include signs of heart failure (except cardiomegaly), thromboembolic events, atrial fibrillation, and atrioventricular block.
  • Diagnostic modalities include echocardiography, MRI, CT, and biopsy; treatment involves diuretics, anticoagulants, and management of arrhythmias, with cardiac transplantation as an option for advanced cases.

    • Impact:

    • Improved understanding of restrictive cardiomyopathies aids in earlier diagnosis and more effective patient management.
    • Highlights the importance of differentiating from constrictive pericarditis for appropriate treatment selection.
    • Emphasizes the need for targeted therapies, especially for specific etiologies like cardiac amyloidosis.